Multidrug Resistant Stenotrophomonas Maltophilia

Total Page:16

File Type:pdf, Size:1020Kb

Multidrug Resistant Stenotrophomonas Maltophilia Jebmh.com Original Research Article Multidrug Resistant Stenotrophomonas maltophilia - Changing Sensitivity Pattern with Resistance to Trimethoprim-Sulfamethoxazole - A Retrospective Study from Jaipur, India Dinesh Kumar Jain1, Yogesh Kumar Gupta2, Parul Sinha3, Sandeep Gupta4, Varunika Vijayvergia5, Sivra Batra6 1, 3, 4, 5, 6 Department of Microbiology, S.M.S. Medical College, Jaipur, Rajasthan, India. 2Department of Microbiology, Fortis Hospital, Jaipur, Rajasthan, India. ABSTRACT BACKGROUND Stenotrophomonas maltophilia is a gram-negative bacillus, multidrug resistant Corresponding Author: (MDR) opportunistic pathogen, which is normally present in hospital surroundings. Dr. Dinesh Kumar Jain, A-734-B Siddartha Nagar-A Near It has been one of the leading causes of nosocomial infections due to risk factors Jawahar Circle Jaipur, such as extended intensive care unit (ICU) stays and multiple invasive procedures. Rajasthan, India. In this study we wanted to assess the antibiotic sensitivity pattern with various E-mail: [email protected] antimicrobial agents i.e. levofloxacin, minocycline, ceftazidime, chloramphenicol, & ticarcillin-clavulanic acid with special focus on trimethoprim-sulfamethoxazole DOI: 10.18410/jebmh/2021/436 (TMP-SMX). How to Cite This Article: METHODS Jain DK, Gupta YK, Sinha P, et al. Multidrug resistant Stenotrophomonas In vitro analysis was conducted on 164 Stenotrophomonas maltophilia strains maltophilia - changing sensitivity pattern isolated from blood and respiratory tract from January 2016 to November 2020. with resistance to trimethoprim- Antibiotic susceptibility and minimum inhibitory concentration (MIC) testing for sulfamethoxazole - a retrospective study trimethoprim-sulfamethoxazole (TMP-SMX), levofloxacin (LVX), ticarcillin - from Jaipur, India. J Evid Based Med clavulanic acid (TIM), and minocycline (MIN) were performed using Vitek 2, as per Healthc 2021;8(26):2339-2343. DOI: clinical and laboratory standards institute (CLSI) guideline. 10.18410/jebmh/2021/436 RESULTS Submission 13-01-2021, Peer Review 20-01-2021, A total of 164 S. maltophilia were isolated. Out of the 164 S. maltophilia isolates, Acceptance 11-05-2021, 26 (16 %) were isolated from blood, 114 (70 %) were isolated from respiratory Published 28-06-2021. samples, 20 (12 %) from pus & tissue, and 4 (2 %) from urine. Out of the 164 patients, 130 (80 %) were males and 32 (20 %) were females. Maximum patients Copyright © 2021 Dinesh Kumar Jain were above 50 years of age 93 (56 %) followed by 20 - 50 years 55 (34 %). Out et al. This is an open access article of the 164 patients, 67 (40 %) were admitted to wards, 92 (56 %) were in ICU distributed under Creative Commons and 5 (3 %) were seen in out-patient department (OPD). A total of 90 % strains Attribution License [Attribution 4.0 were sensitive to trimethoprim-sulfamethoxazole (TMP-SMX). Total 91 % strains International (CC BY 4.0)] were sensitive to levofloxacin. CONCLUSIONS S. maltophilia is emerging as a significant nosocomial pathogen, with a growing rate of isolation. Trimethoprim- sulfamethoxazole (TMP-SMX) is still the drug of choice, but resistance to it has been reported. KEYWORDS Minimum Inhibitory Concentration, Trimethoprim-Sulfamethoxazole (TMP-SMX), Levofloxacin J Evid Based Med Healthc, pISSN - 2349-2562, eISSN - 2349-2570 / Vol. 8 / Issue 26 / June 28, 2021 Page 2339 Jebmh.com Original Research Article BACKGROUND disease has arisen as a serious concern in patients with no known risk factors, such as intensive critical unit stay; Medical microbiologists have long realized the significance of treatment-induced neutropenia, mechanical ventilation, long identifying infectious microbes as the cause of ailments in carbapenem therapy, third or fourth cephalosporins, or long human beings. The emergence of novel multidrug-resistant hospital stays. In all geographic regions, this bacterium is bugs found in atmosphere, the growing incidents of most commonly associated with respiratory tract infections. community-acquired infections, and the spread of these Any organ may be affected by Stenotrophomonas microorganisms in the hospital setting have all emphasized maltophilia. Infections of the lungs are common. the necessity to control these pathogens. The increasing Colonization of the respiratory tract normally precedes lung incidents of multidrug-resistant organisms (MDRO) infection. Pleural effusions are uncommon, but lobar or lobar associated infections has spurred efforts to examine consolidation is common. Infected indwelling intravascular potential sources of these pathogens, evaluate current devices cause the most of the Stenotrophomonas antimicrobial strategies used to treat these infections, and maltophilia bloodstream infections. Non–catheter-related explain the mechanisms used by these microbial pathogens bacteraemia is often seen in patients with prolonged 4,5,6 during infection. Gram-negative bacilli have received a lot of neutropenia. attention, as they are frequently associated with multidrug- Trimethoprim-sulfamethoxazole / Co-trimoxazole has resistant mechanisms which include multidrug resistance been the primary treatment for susceptible S. maltophilia pumps, plasmids that harbour antibiotic resistance genetic infections, based on in vitro activity and anecdotal reports of materials, and various gene transfer methods involved in the favourable clinical outcomes. Although levofloxacin and acquisition of antimicrobial resistance. Pseudomonas Minocycline have been considered as alternatives to (TMP- aeruginosa is an example of a multidrug-resistant organism SMX) for the treatment of Stenotrophomonas maltophilia that causes respiratory infections in patients with chronic infections, more clinical data are still needed to validate their 4,6,7,8 lung disease or cystic fibrosis. efficacies. Stenotrophomonas maltophilia was first isolated in 1943 Because Stenotrophomonas maltophilia and B. cepacia and was named Bacterium bookeri by J. L. Edward at that are present in the atmosphere, exposure to these bacteria time. It was later renamed in the Pseudomonas family, then occurs frequently. Bacterial factors contributing to family Xanthomonas, and finally, in 1993, after a very long colonization of the respiratory tract or prosthetic devices period of debate, Palleroni and Bradbury proposed a genus such as intravascular catheters and endotracheal tubes Stenotrophomonas. include cationic surface charge, flagella and fimbriae, which 9,10 It is the only Stenotrophomonas species known to infect promote adhesion and biofilm formation. human being, while its close genetic members are only Patients at high risk for infection are those critically ill infective to plants. Stenotrophomonas maltophilia is an with (1) chronic obstructive pulmonary disease (2) aerobic non-fermentative gram-negative bacillus that is prolonged use of broad-spectrum anti-microbial therapy ubiquitous in the environment in all geographic regions.1,2 with third and fourth generation cephalosporin’s or It acquire motility via multi trichous flagella. The optimal carbapenem’s (3) prolonged need for assisted ventilation temperature for its growth is 35°C- 37°C and no growth requiring tracheotomy (4) high injury severity score (5) occurs below 5°C and above 40°C. It produces lavender- pulmonary contusion and (6) prior respiratory tract S. 11 green color colonies on blood agar (BA) plates, non- maltophilia colonization. pigmented small colonies on MacConkey agar (MHA) plates In the immunosuppressed cancer and transplant and tiny creamy colonies on Muller-Hinton agar (MHA) plates population, well-recognized risk factors for invasive S. after 18 – 24 hours of incubation at 35°C - 37°C. maltophilia disease include (1) presence of long treatment- They do not ferment glucose sugar, and many isolates induced neutropenia (absolute neutrophil count < 150 tend to give a positive oxidase test. These free-living micro- cells/μL) (2) recent or on-going carbapenem, higher- organisms are present in most aquatic and/or humid generation cephalosporin, or fluoroquinolone therapy (3) environment, including hospital drinking water. presence of mucositis (4) presence of indwelling medical Stenotrophomonas maltophilia has arisen as an devices such as intravascular or genitourinary catheters (5) 12,13 important opportunistic nosocomial pathogen, particularly prolonged hospital stay and (6) hyper alimentation. S. among immune-compromised hosts, patients suffering from maltophilia in chlorine treated water distribution hospital malignancy, patients on long steroid therapy and prolonged water supply has been identified as a source for occasional 14 hospitalization. S. maltophilia is a significant nosocomial clusters of nosocomial cases. pathogen that is now considered as a "newly emerging Several molecular mechanisms of S. maltophilia superbug" due to its multi-drug resistance and ability to contributes to its multi-antimicrobial resistance, including, colonise the surfaces of medical devices. S. maltophilia can plasmids, integrons, and jumping genes. Integrons common cause a wide variety of infections, including nosocomial regions and integron-like elements have been reported for pneumonia, acute exacerbations of chronic obstructive S. maltophilia isolates across the world. Integrons are not pulmonary disease (COPD), urinary tract infections (UTI), auto-mobilizable parts but hold an integrase encoding gene bacteraemia, endocarditis, meningitis, and wound & soft that allows the insertion of antibiotic resistance gene tissue infections.3
Recommended publications
  • International Journal of Advanced Research in Biological Sciences ISSN: 2348-8069 Coden: IJARQG(USA) Research Article
    Int. J. Adv. Res. Biol. Sci. (2016). 3(1): 174-185 International Journal of Advanced Research in Biological Sciences ISSN: 2348-8069 www.ijarbs.com Coden: IJARQG(USA) Research Article SOI: http://s-o-i.org/1.15/ijarbs-2016-3-1-23 Isolation, identification and characterization of BTX degrading Stenotrophomonas sp. TS48 strain obtained from Egyptian saline soil Mamdouh S. El-Gamal1*, Said E. Desouky1 and Mohammed G. Barghoth1 1*Botany &Microbiology Dept., Faculty of Science (Boys), Al-Azhar University, 11884 Nasr City, Cairo, Egypt *Corresponding author: [email protected] Abstract BTX compounds are monoaromatic hydrocarbon pollutants that are toxic to the human health and environment. It is one of the most stable compounds in soils, ground and surface waters, therefore its biodegrading is worthy to be undertaken. In the present investigation, thirty nine halophilic bacterial isolates capable to utilize toluene as the only carbon source. They were isolated from alkaline soils in Al- Hamra Lake, Wadi ElNatrun, Egypt. Based on the highest degradation of toluene, isolate TS48 was selected as the most potent isolate. The isolate is belonging to family Xanthomonadaceae of the subclass Proteobacteria and was identified as Stenotrophomonas sp. TS48 according to the 16S rRNA gene sequence and phenotypic characterizations. Strain TS48 was very closely related to Stenotrophomonas acidaminiphila AMX 19, Stenotrophomonas nitritireducens L2 and Stenotrophomonas terrae R-32768 with similarity levels at 97, 96 and 96% respectively. Strain TS48showed better growth at a wide range of temperatures between 20 up to 40 ºC, pH values 6 to 9 and salt concentrations from 2.5 to 10%.
    [Show full text]
  • Characterization of Bacterial Communities Associated
    www.nature.com/scientificreports OPEN Characterization of bacterial communities associated with blood‑fed and starved tropical bed bugs, Cimex hemipterus (F.) (Hemiptera): a high throughput metabarcoding analysis Li Lim & Abdul Hafz Ab Majid* With the development of new metagenomic techniques, the microbial community structure of common bed bugs, Cimex lectularius, is well‑studied, while information regarding the constituents of the bacterial communities associated with tropical bed bugs, Cimex hemipterus, is lacking. In this study, the bacteria communities in the blood‑fed and starved tropical bed bugs were analysed and characterized by amplifying the v3‑v4 hypervariable region of the 16S rRNA gene region, followed by MiSeq Illumina sequencing. Across all samples, Proteobacteria made up more than 99% of the microbial community. An alpha‑proteobacterium Wolbachia and gamma‑proteobacterium, including Dickeya chrysanthemi and Pseudomonas, were the dominant OTUs at the genus level. Although the dominant OTUs of bacterial communities of blood‑fed and starved bed bugs were the same, bacterial genera present in lower numbers were varied. The bacteria load in starved bed bugs was also higher than blood‑fed bed bugs. Cimex hemipterus Fabricus (Hemiptera), also known as tropical bed bugs, is an obligate blood-feeding insect throughout their entire developmental cycle, has made a recent resurgence probably due to increased worldwide travel, climate change, and resistance to insecticides1–3. Distribution of tropical bed bugs is inclined to tropical regions, and infestation usually occurs in human dwellings such as dormitories and hotels 1,2. Bed bugs are a nuisance pest to humans as people that are bitten by this insect may experience allergic reactions, iron defciency, and secondary bacterial infection from bite sores4,5.
    [Show full text]
  • Targeting the Burkholderia Cepacia Complex
    viruses Review Advances in Phage Therapy: Targeting the Burkholderia cepacia Complex Philip Lauman and Jonathan J. Dennis * Department of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9, Canada; [email protected] * Correspondence: [email protected]; Tel.: +1-780-492-2529 Abstract: The increasing prevalence and worldwide distribution of multidrug-resistant bacterial pathogens is an imminent danger to public health and threatens virtually all aspects of modern medicine. Particularly concerning, yet insufficiently addressed, are the members of the Burkholderia cepacia complex (Bcc), a group of at least twenty opportunistic, hospital-transmitted, and notoriously drug-resistant species, which infect and cause morbidity in patients who are immunocompromised and those afflicted with chronic illnesses, including cystic fibrosis (CF) and chronic granulomatous disease (CGD). One potential solution to the antimicrobial resistance crisis is phage therapy—the use of phages for the treatment of bacterial infections. Although phage therapy has a long and somewhat checkered history, an impressive volume of modern research has been amassed in the past decades to show that when applied through specific, scientifically supported treatment strategies, phage therapy is highly efficacious and is a promising avenue against drug-resistant and difficult-to-treat pathogens, such as the Bcc. In this review, we discuss the clinical significance of the Bcc, the advantages of phage therapy, and the theoretical and clinical advancements made in phage therapy in general over the past decades, and apply these concepts specifically to the nascent, but growing and rapidly developing, field of Bcc phage therapy. Keywords: Burkholderia cepacia complex (Bcc); bacteria; pathogenesis; antibiotic resistance; bacterio- phages; phages; phage therapy; phage therapy treatment strategies; Bcc phage therapy Citation: Lauman, P.; Dennis, J.J.
    [Show full text]
  • Antimicrobial Peptide Exposure Selects for Resistant and Fit Downloaded from Stenotrophomonas Maltophilia Mutants That Show Cross- Resistance to Antibiotics
    RESEARCH ARTICLE Therapeutics and Prevention crossm Antimicrobial Peptide Exposure Selects for Resistant and Fit Downloaded from Stenotrophomonas maltophilia Mutants That Show Cross- Resistance to Antibiotics Paula Blanco,a* Karin Hjort,b José L. Martínez,a Dan I. Anderssonb a Centro Nacional de Biotecnología, CSIC, Madrid, Spain http://msphere.asm.org/ bDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden ABSTRACT Antimicrobial peptides (AMPs) are essential components of the innate immune system and have been proposed as promising therapeutic agents against drug-resistant microbes. AMPs possess a rapid bactericidal mode of action and can interact with different targets, but bacteria can also avoid their effect through a vari- ety of resistance mechanisms. Apart from hampering treatment by the AMP itself, or that by other antibiotics in the case of cross-resistance, AMP resistance might also confer cross-resistance to innate human peptides and impair the anti-infective capa- bility of the human host. A better understanding of how resistance to AMPs is ac- quired and the genetic mechanisms involved is needed before using these com- on February 5, 2021 at Red de Bibliotecas del CSIC pounds as therapeutic agents. Using experimental evolution and whole-genome sequencing, we determined the genetic causes and the effect of acquired de novo resistance to three different AMPs in the opportunistic pathogen Stenotrophomonas maltophilia, a bacterium that is intrinsically resistant to a wide range of antibiotics. Our results show that AMP exposure selects for high-level resistance, generally with- out any reduction in bacterial fitness, conferred by mutations in different genes en- coding enzymes, transporters, transcriptional regulators, and other functions.
    [Show full text]
  • Non-Lethal Effects of N-Acetylcysteine on Xylella
    microorganisms Article Non-Lethal Effects of N-Acetylcysteine on Xylella fastidiosa Strain De Donno Biofilm Formation and Detachment Cristina Cattò 1 , Luca De Vincenti 1, Francesca Cappitelli 1 , Giusy D’Attoma 2, Maria Saponari 2 , Federica Villa 1,* and Fabio Forlani 1 1 Department of Food, Environmental and Nutritional Sciences, Università degli Studi di Milano, via Celoria 2, 20133 Milano, Italy; [email protected] (C.C.); [email protected] (L.D.V.); [email protected] (F.C.); [email protected] (F.F.) 2 Institute for Sustainable Plant Protection, Consiglio Nazionale delle Ricerche, via Amendola 165/A, 70126 Bari, Italy; [email protected] (G.D.); [email protected] (M.S.) * Correspondence: [email protected]; Tel.: +39-02-503-19121 Received: 11 October 2019; Accepted: 3 December 2019; Published: 5 December 2019 Abstract: This study investigated in-vitro the non-lethal effects of N-acetylcysteine (NAC) on Xylella fastidiosa subspecies pauca strain De Donno (Xf-DD) biofilm. This strain was isolated from the olive trees affected by the olive quick decline syndrome in southern Italy. Xf-DD was first exposed to non-lethal concentrations of NAC from 0.05 to 1000 µM. Cell surface adhesion was dramatically reduced at 500 µM NAC ( 47%), hence, this concentration was selected for investigating the effects of pre-, post- − and co-treatments on biofilm physiology and structural development, oxidative homeostasis, and biofilm detachment. Even though 500 µM NAC reduced bacterial attachment to surfaces, compared to the control samples, it promoted Xf-DD biofilm formation by increasing: (i) biofilm biomass by up to 78% in the co-treatment, (ii) matrix polysaccharides production by up to 72% in the pre-treatment, and (iii) reactive oxygen species levels by 3.5-fold in the co-treatment.
    [Show full text]
  • Novel Virulent Bacteriophages Infecting Mediterranean Isolates of the Plant Pest Xylella Fastidiosa and Xanthomonas Albilineans
    viruses Article Novel Virulent Bacteriophages Infecting Mediterranean Isolates of the Plant Pest Xylella fastidiosa and Xanthomonas albilineans Fernando Clavijo-Coppens 1,2,3 , Nicolas Ginet 1 , Sophie Cesbron 2 , Martial Briand 2, Marie-Agnès Jacques 2 and Mireille Ansaldi 1,* 1 Laboratoire de Chimie Bactérienne, UMR7283, Centre National de la Recherche Scientifique, Aix-Marseille Université, 13009 Marseille, France; [email protected] (F.C.-C.); [email protected] (N.G.) 2 Institute Agro, INRAE, IRHS, SFR QUASAV, University of Angers, 49000 Angers, France; [email protected] (S.C.); [email protected] (M.B.); [email protected] (M.-A.J.) 3 Bioline-Agrosciences, Equipe R&D–Innovation, 06560 Valbonne, France * Correspondence: [email protected]; Tel.: +33-491164585 Abstract: Xylella fastidiosa (Xf ) is a plant pathogen causing significant losses in agriculture worldwide. Originating from America, this bacterium caused recent epidemics in southern Europe and is thus considered an emerging pathogen. As the European regulations do not authorize antibiotic treatment in plants, alternative treatments are urgently needed to control the spread of the pathogen and eventually to cure infected crops. One such alternative is the use of phage therapy, developed more than 100 years ago to cure human dysentery and nowadays adapted to agriculture. The first step towards phage therapy is the isolation of the appropriate bacteriophages. With this goal, we searched Citation: Clavijo-Coppens, F.; Ginet, for phages able to infect Xf strains that are endemic in the Mediterranean area. However, as Xf N.; Cesbron, S.; Briand, M.; Jacques, is truly a fastidious organism, we chose the phylogenetically closest and relatively fast-growing M.-A.; Ansaldi, M.
    [Show full text]
  • Biofilm Formation Among Stenotrophomonas
    microorganisms Article Biofilm Formation among Stenotrophomonas maltophilia Isolates Has Clinical Relevance: The ANSELM Prospective Multicenter Study Arianna Pompilio 1,2,* , Marco Ranalli 1,2, Alessandra Piccirilli 3, Mariagrazia Perilli 3 , Dragana Vukovic 4 , Branislava Savic 4, Marcela Krutova 5, Pavel Drevinek 5, Daniel Jonas 6, Ersilia V. Fiscarelli 7, Vanessa Tuccio Guarna Assanti 7, María M. Tavío 8, Fernando Artiles 9 and Giovanni Di Bonaventura 1,2 1 Laboratory of Clinical Microbiology, Department of Medical, Oral and Biotechnological Sciences, “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy; [email protected] (M.R.); [email protected] (G.D.B.) 2 Operative Unit of Clinical Microbiology, Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti, Italy 3 Department of Biotechnological and Applied Clinical Sciences, Health and Environmental Sciences, University of L’Aquila, 67100 L’Aquila, Italy; [email protected] (A.P.); [email protected] (M.P.) 4 Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia; [email protected] (D.V.); [email protected] (B.S.) 5 Department of Medical Microbiology, 2nd Faculty of Medicine and Motol University Hospital, Charles University, 15006 Prague, Czech Republic; [email protected] (M.K.); [email protected] (P.D.) 6 University Freiburg—Medical Center, Institute for Infection Prevention and
    [Show full text]
  • Characterization of N2O-Producing Xanthomonas-Like Isolates from Biofilters As Stenotrophomonas Nitritireducens Sp
    International Journal of Systematic and Evolutionary Microbiology (2000), 50, 273–282 Printed in Great Britain Characterization of N2O-producing Xanthomonas-like isolates from biofilters as Stenotrophomonas nitritireducens sp. nov., Luteimonas mephitis gen. nov., sp. nov. and Pseudoxanthomonas broegbernensis gen. nov., sp. nov. Wolfgang Finkmann,1 Karlheinz Altendorf,1 Erko Stackebrandt2 and Andre! Lipski1 Author for correspondence: Andre! Lipski. Tel: ­49 541 969 2276. Fax: ­49 541 969 2870. e-mail: Lipski!biologie.uni-osnabrueck.de 1 Abteilung Mikrobiologie, A group of yellow-pigmented isolates from ammonia-supplied biofilters Fachbereich showed an unusual denitrification reaction. All strains reduced nitrite but not Biologie/Chemie, Universita$ t Osnabru$ ck, nitrate without production of nitrogen (N2). The only product found was Osnabru$ ck, Germany nitrous oxide (N2O). The strains were divided into two clusters and one 2 Deutsche Sammlung fu$ r separate strain by their fatty acid profiles, which were similar to the fatty acid Mikroorganismen und profiles of the genera Xanthomonas and Stenotrophomonas. Analyses of the Zellkulturen GmbH, 16S rDNA sequences showed that these clusters and the separate strain form Braunschweig, Germany three independent lines within the Xanthomonas branch of the Proteobacteria. The evolutionary distances of the isolates to members of the related genera Xanthomonas, Stenotrophomonas and Xylella calculated by the 16S rDNA sequences led to the proposal of two new genera and three new species, Stenotrophomonas nitritireducens sp. nov., Luteimonas mephitis gen. nov., sp. nov. and Pseudoxanthomonas broegbernensis gen. nov., sp. nov. The type strains are Stenotrophomonas nitritireducens L2T (¯ DSM 12575T), Luteimonas mephitis B1953/27.1T (¯ DSM 12574T) and Pseudoxanthomonas broegbernensis B1616/1T (¯ DSM 12573T).
    [Show full text]
  • Stenotrophomonas Maltophilia and Burkholderia Cepacia Isolated
    For more information, contact: C1024 In Vitro Activity of Minocycline Against Acinetobacter baumannii, Robert K. Flamm, PhD JMI Laboratories Stenotrophomonas maltophilia and Burkholderia cepacia Isolated 345 Beaver Kreek Ctr, Ste A North Liberty, Iowa, 52317, USA During 2013 from a Global Surveillance Program Phone: 319-665-3370 Fax: 319-665-3371 Robert K Flamm, Mariana Castanheira, David J Farrell, Jennifer M Streit, Ronald N Jones — JMI Laboratories, North Liberty, Iowa, USA [email protected] Abstract Introduction Results Conclusions Background The tetracyclines were one of the early discovered broad- Acinetobacter baumannii Table 1. Summary of minocycline activity tested against selected Gram-negative bacteria isolates from global surveillance (2013) • Minocycline susceptibility rate against Acinetobacter spectrum antimicrobial classes which were found in the 1940s, Minocycline (MIN) is a second generation tetracycline (TET) which is one A total of 81.6% of A. baumannii and were baumannii (81.6% of them MDR) was 72.3%, the second with activity against Gram-positive and -negative bacteria. No. of isolates (cumulative %) inhibited at minocycline MIC (μg/mL) of: MIC (μg/mL) of a few agents approved by the USA-FDA for treatment of Acinetobacter MDR (Table 1). The percentages of MDR highest after colistin (96.4% susceptible) and significantly Development of enhanced compounds, second- and third- Organism (Number of isolates) 0.015 0.03 0.06 0.12 0.25 0.5 1 2 4 8 > 8 MIC50 MIC90 infections. In this study, the activity of MIN and comparators was varied by region from 61.7% in North generation semisynthetic compounds, has improved the range Acinetobacter baumannii complex (1,312) 6 (0.5) 40 (3.5) 100 (11.1) 109 (19.4) 126 (29.0) 160 (41.2) 109 (49.5) 120 (58.7) 178 (72.3) 199 (87.4) 165 (100.0) 2 > 8 higher than doxycycline (53.4%).
    [Show full text]
  • Identification of Pseudomonas Species and Other Non-Glucose Fermenters
    UK Standards for Microbiology Investigations Identification of Pseudomonas species and other Non- Glucose Fermenters Issued by the Standards Unit, Microbiology Services, PHE Bacteriology – Identification | ID 17 | Issue no: 3 | Issue date: 13.04.15 | Page: 1 of 41 © Crown copyright 2015 Identification of Pseudomonas species and other Non-Glucose Fermenters Acknowledgments UK Standards for Microbiology Investigations (SMIs) are developed under the auspices of Public Health England (PHE) working in partnership with the National Health Service (NHS), Public Health Wales and with the professional organisations whose logos are displayed below and listed on the website https://www.gov.uk/uk- standards-for-microbiology-investigations-smi-quality-and-consistency-in-clinical- laboratories. SMIs are developed, reviewed and revised by various working groups which are overseen by a steering committee (see https://www.gov.uk/government/groups/standards-for-microbiology-investigations- steering-committee). The contributions of many individuals in clinical, specialist and reference laboratories who have provided information and comments during the development of this document are acknowledged. We are grateful to the Medical Editors for editing the medical content. For further information please contact us at: Standards Unit Microbiology Services Public Health England 61 Colindale Avenue London NW9 5EQ E-mail: [email protected] Website: https://www.gov.uk/uk-standards-for-microbiology-investigations-smi-quality- and-consistency-in-clinical-laboratories
    [Show full text]
  • Multiple Antibiotics Resistant Among Environmental Isolates of Stenotrophomonas Maltophilia
    JASEM ISSN 1119-8362 Full-text Available Online at J. Appl. Sci. Environ. Manage. June 2014 JOURNAL OF APPLIED SCIENCE AND ENVIRONVol.ME N18T (A2)L 25M5-A2N61A GEMENT. All rights reserved www.ajol.info and www.bioline.org.br/ja Multiple antibiotics resistant among environmental isolates of Stenotrophomonas maltophilia *ETINOSA O. IGBINOSA, FAITH E. OVIASOGIE Department of Microbiology, Faculty of Life Sciences, University of Benin, Private Mail Bag 1154, Benin City 300001, Nigeria ABSTRACT: In this study we assessed the functionality of integrons, melanin-like pigment and biofilm formation on multidrug resistance among environmental isolates of Stenotrophomonas maltophilia. Marked resistances were noted against aztreonam (60%), cefepime (68%), ceftazidime (77%), ciprofloxacin (72%), gentamicin (65%), meropenem (75%), piperacillin/tazobactam (65%) in S. maltophilia. Ticarcillin/clavulanic acid (66%) and trimethoprim/sulfamethoxazole (75%) were the active antibiotics against S. maltophilia. Class 1 intergron was significantly detected in 56.3% (54/96) of S. maltophilia strains. Integron-positive strains were significantly resistant to cefepime (69%), ceftazidime (78%), ciprofloxacin (74%), gentamicin (65%), and meropenem (72%). Gene cassettes arrays within integrons were identified as aminoglycoside resistance genes aacA4, aadA2, aadB, aacC4, and aacA6'-Ib; β- lactams resistance genes blaIMP, blaOXA, and blaCARB; chloramphenicol resistance genes cmlA and catB2; quaternary ammonium compound (QAC) resistance genes smr and qac; and multi-gene cassettes: smr/aacA4 and blaIMP/aac6-II/aadA5. High-pigment-producing S. maltophilia strains revealed significant correlation with resistance to cefepime, ceftazidime, ciprofloxacin, levofloxacin and piperacillin/ tazobactam. Biofilm formation was not significant with resistance to ciprofloxacin, levofloxacin, meropenem, ticarcillin/clavulanic and trimethoprim /sulfamethoxazole. Our findings characterize the significant roles of integrons, melanin-like pigment and biofilm formation in the multidrug resistance of S.
    [Show full text]
  • Taxonomy and Physiology of Pseudoxanthomonas Arseniciresistens Sp
    RESEARCH ARTICLE Taxonomy and physiology of Pseudoxanthomonas arseniciresistens sp. nov., an arsenate and nitrate-reducing novel gammaproteobacterium from arsenic contaminated groundwater, India Balaram Mohapatra1, Pinaki Sar1*, Sufia Khannam Kazy2, Mrinal Kumar Maiti1, a1111111111 Tulasi Satyanarayana3 a1111111111 a1111111111 1 Department of Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur, West Bengal, India, 2 Department of Biotechnology, National Institute of Technology Durgapur, Durgapur, West Bengal, India, a1111111111 3 Department of Microbiology, University of Delhi South Campus (UDSC), New Delhi, Delhi, India a1111111111 * [email protected] Abstract OPEN ACCESS Citation: Mohapatra B, Sar P, Kazy SK, Maiti MK, Reductive transformation of toxic arsenic (As) species by As reducing bacteria (AsRB) is a key Satyanarayana T (2018) Taxonomy and physiology process in As-biogeochemical-cycling within the subsurface aquifer environment. In this study, of Pseudoxanthomonas arseniciresistens sp. nov., we have characterized a Gram-stain-negative, non-spore-forming, rod-shaped As reducing an arsenate and nitrate-reducing novel T gammaproteobacterium from arsenic bacterium designated KAs 5-3 , isolated from highly As-contaminated groundwater of India. contaminated groundwater, India. PLoS ONE 13 Strain KAs 5-3T displayed high 16S rRNA gene sequence similarity to the members of the (3): e0193718. https://doi.org/10.1371/journal. genus Pseudoxanthomonas, with P. mexicana AMX 26BT (99.25% similarity), P. japonensis pone.0193718 12-3T (98.90%), P. putridarboris WD-12T (98.02%), and P. indica P15T (97.27%) as closest Editor: Olga Cristina Pastor Nunes, University of phylogenetic neighbours. DNA-DNA hybridization study unambiguously indicated that strain Porto, PORTUGAL KAs 5-3T represented a novel species that was separate from reference strains of P.
    [Show full text]